HLRCC is a rare autosomal-dominant syndrome defined by the triad of cutaneous leiomyomas, uterine leiomyomas, and fumarate hydratase (FH)–deficient renal cell carcinoma (RCC) [1–2]. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.